This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stryker Corporation (SYK)

NYSE: Health Care

  • Latest Dividend: 0.34
  • Latest Dividend Yield: 1.49%
  • Dividend Ex-Date: 12/29/14
  • Price Earnings Ratio: 68.903
  • Price Earnings Comparisons:
    SYK Sector Avg. S&P 500
    68.90 55.10 25.85
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    7.61% 19.77% 68.94%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 4.20 0.23 0.07
    Net Income -22.50 -0.21 -0.07
    EPS -22.30 -0.17 -0.06
  • Earnings for SYK:
    EBITDA 1.61B
    REVENUE 9.02B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $1.09 $1.17 $5.00 $5.45
Number of Analysts 13 13 15 13
High Estimate $1.12 $1.23 $5.10 $5.55
Low Estimate $1.06 $1.14 $4.94 $5.31
Prior Year $1.06 $1.08 $n.a. $5.00
Growth Rate (Year over Year) 2.76% 8.12% n.a.% 8.97%
SYK News

SYK Stryker Corporation

Analysts Ratings for SYK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 9 10 11
Moderate Buy 2 2 1 1
Hold 7 6 6 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SYK ANALYST REPORT

Brokerage Partners

SYK Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs